Medication non-adherence continues to be a big issue in the pharma industry, affecting clinical outcomes for both approved and investigational drugs. Sponsors, research organizations, and payers are looking to verify that what they’re studying or paying for is actually being used as directed. Various technologies, such as Proteus and AiCure, are being examined for these exact reasons.
This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
From a pharmaceutical development standpoint, new forms of medication are being created. Aprecia Pharmaceuticals’ SPRITAM® is leveraging ZipDose® technology, a manufacturing process that makes the medication disintegrate in seconds with a sip of liquid, increasing the likelihood of adherence. In 2016, we will see more life sciences companies testing ways to improve medication adherence.
To learn about other new trends that we can also expect to see in 2016, fill out the form below or click here.